MedComm

Keyphrases

Publications

volume 5, number 9, 2024

Peng Sun, Juanjuan Liu, Deliang Guo
Tumor cells utilize acetate for tumor growth and immune evasion. MedComm 5 (9) (2024)
Yan Liu, Nannan Zhang, Yi Wen, Jiaolin Wen
Head and neck cancer: pathogenesis and targeted therapy. MedComm 5 (9) (2024)
Rubing Xue, Sijia Liu, Fangfang Zhou
Enhancing the effectiveness of anti-respiratory virus vaccines by bolstering mucosal immunity and cellular defenses. MedComm 5 (9) (2024)
Jiangchun Wu, Yong Wu, Tianyi Zhao, Xiangwei Wang, Qinhao Guo, Simin Wang, Siyu Chen, Xingzhu Ju, Jin Li, Xiaohua Wu, Zhong Zheng
Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21-activated kinase 4. MedComm 5 (9) (2024)
Liang Cheng, Chenwei Yang, Junlin Lu, Ming Huang, Ruihui Xie, Sarah Lynch, Justin Elfman, Yuhang Huang, Sen Liu, Siting Chen, Baoqing He, Tianxin Lin, Hui Li, Xu Chen, Jian Huang
Oncogenic SLC2A11-MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability. MedComm 5 (9) (2024)
Lunbo Tan, Na Wang, Annet M H Galema-Boers, Leonie van Vark-van der Zee, Jeanine Roeters van Lennep, Monique T Mulder, Xifeng Lu, A H Jan Danser, Koen Verdonk
Statins, but not proprotein convertase subtilisin-kexin type 9 inhibitors, lower chemerin in hypercholesterolemia via low-density lipoprotein receptor upregulation. MedComm 5 (9) (2024)
Yingying Liu, Chunling Xu, Renjun Gu, Ruiqin Han, Ziyu Li, Xianrong Xu
Endoplasmic reticulum stress in diseases. MedComm 5 (9) (2024)
Xuejin Ou, Ge Gao, Inbar A Habaz, Yongsheng Wang
Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies. MedComm 5 (9) (2024)
Liang Ma, Jie Yu, Yidian Fu, Xiaoyu He, Shengfang Ge, Renbing Jia, Ai Zhuang, Zhi Yang, Xianqun Fan
The dual role of cellular senescence in human tumor progression and therapy. MedComm 5 (9) (2024)
Yu-Qing Jin, Hang Yuan, Ya-Fang Liu, Yi-Wen Zhu, Yan Wang, Xiao-Yi Liang, Wei Gao, Zhi-Guang Ren, Xin-Ying Ji, Dong-Dong Wu
Role of hydrogen sulfide in health and disease. MedComm 5 (9) (2024)
Yue Zheng, Xinming Su, Shiwei Duan
The stiffness of the extracellular matrix is a key factor in tumor progression. MedComm 5 (9) (2024)
Meng Wang, Juepu Zhou, Rui Long, Yuehan Li, Limin Gao, Ruolin Mao, Xiangfei Wang, Na Guo, Lei Jin, Lixia Zhu
Recryopreservation impairs blastocyst implantation potential via activated endoplasmic reticulum stress pathway and induced apoptosis. MedComm 5 (9) (2024)
Shaohui Wang, Sa Guo, Jing Guo, Qinyun Du, Cen Wu, Yeke Wu, Yi Zhang
Cell death pathways: molecular mechanisms and therapeutic targets for cancer. MedComm 5 (9) (2024)
Jiang Ren, Sijia Liu, Long Zhang
Inhibitor of differentiation 3 confers the robust anti-tumor activity of Kupffer cells. MedComm 5 (9) (2024)
Yaqing Qie, Martha E Gadd, Qing Shao, Tommy To, Andrew Liu, Shuhua Li, Rocio Rivera-Valentin, Farah Yassine, Hemant S Murthy, Roxana Dronca, Mohamed A Kharfan-Dabaja, Hong Qin, Yan Luo
Targeting chronic lymphocytic leukemia with B-cell activating factor receptor CAR T cells. MedComm 5 (9) (2024)
Yingying Liu, Chunling Xu, Renjun Gu, Ruiqin Han, Ziyu Li, Xianrong Xu
Endoplasmic reticulum stress in diseases. MedComm 5 (9) (2024)
Modan Yang, Zuyuan Lin, Li Zhuang, Linhui Pan, Rui Wang, Hao Chen, Zhihang Hu, Wei Shen, Jianyong Zhuo, Xinyu Yang, Huigang Li, Chiyu He, Zhe Yang, Qinfen Xie, Siyi Dong, Junli Chen, Renyi Su, Xuyong Wei, Junjie Yin, Shusen Zheng, Di Lu, Xiao Xu
An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. MedComm 5 (9) (2024)
Yingjie Wang, Hongyu Liu, Mengsha Zhang, Jing Xu, Liuxian Zheng, Pengpeng Liu, Jingyao Chen, Hongyu Liu, Chong Chen
Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives. MedComm 5 (9) (2024)
Jiang Ren, Sijia Liu, Long Zhang
Inhibitor of differentiation 3 confers the robust anti-tumor activity of Kupffer cells. MedComm 5 (9) (2024)
Xiao-Hui Zheng, Xi-Zhao Li, Cao-Li Tang, Yu-Meng Zhang, Ting Zhou, Xiao-Jing Yang, Ying Liao, Yong-Qiao He, Tong-Min Wang, Wen-Qiong Xue, Wei-Hua Jia
Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash. MedComm 5 (9) (2024)
Yan Liu, Nannan Zhang, Yi Wen, Jiaolin Wen
Head and neck cancer: pathogenesis and targeted therapy. MedComm 5 (9) (2024)
Meng Wang, Juepu Zhou, Rui Long, Yuehan Li, Limin Gao, Ruolin Mao, Xiangfei Wang, Na Guo, Lei Jin, Lixia Zhu
Recryopreservation impairs blastocyst implantation potential via activated endoplasmic reticulum stress pathway and induced apoptosis. MedComm 5 (9) (2024)
Xiaoyan Lu, Lingqi Yu, Jie Zheng, Anyao Li, Junying Li, He Lou, Wentao Zhang, Hui Guo, Yuzhen Wang, Xuemei Li, Yue Gao, Xiaohui Fan, Jürgen Borlak
miR-106b-5p protects against drug-induced liver injury by targeting vimentin to stimulate liver regeneration. MedComm 5 (9) (2024)
Fanfei Liu, Ruiting Li, Zilin Zhu, Yang Yang, Fang Lu
Current developments of gene therapy in human diseases. MedComm 5 (9) (2024)
Dandan Peng, Cai He, Zimin Chen, Hong Lei, Xiya Huang, Chunjun Ye, Binhan Wang, Ying Hao, Xinyi Du, Shuaiyao Lu, Hongbo Hu, Wei Cheng, Haohao Dong, Jian Lei, Xi-Kun Zhou, Xiangrong Song, Guangwen Lu, Yanping Qian
XBB.1.16-RBD-based trimeric protein vaccine can effectively inhibit XBB.1.16-included XBB subvariant infection. MedComm 5 (9) (2024)
Ting Xiao, Shiqi Li, Xinghua Long
SMARCAL1: a new target for taming tumor immune evasion. MedComm 5 (9) (2024)
Liang Cheng, Chenwei Yang, Junlin Lu, Ming Huang, Ruihui Xie, Sarah Lynch, Justin Elfman, Yuhang Huang, Sen Liu, Siting Chen, Baoqing He, Tianxin Lin, Hui Li, Xu Chen, Jian Huang
Oncogenic SLC2A11-MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability. MedComm 5 (9) (2024)
Guang Yang, Abbas Khan, Wei Liang, Zibo Xiong, Johannes Stegbauer
Aortic aneurysm: pathophysiology and therapeutic options. MedComm 5 (9) (2024)
Yuanyong Wang, Jin Zhang, Yuchen Yang, Zhuofeng Liu, Sijia Sun, Rui Li, Hui Zhu, Tian Li, Jin Zheng, Jie Li, Li-Tian Ma
Circular RNAs in human diseases. MedComm 5 (9) (2024)
Xiaomin Liu, Fan Wu, Wei Pan, Guangchao Liu, Hui Zhang, Dawei Yan, Saijing Zheng, Zhongliang Ma, Xiaojun Ren
Tumor-associated exosomes in cancer progression and therapeutic targets. MedComm 5 (9) (2024)
Peng Sun, Juanjuan Liu, Deliang Guo
Tumor cells utilize acetate for tumor growth and immune evasion. MedComm 5 (9) (2024)
Xiaoyou Liu, Junyi Shen, Hongyan Yan, Jianmin Hu, Guorong Liao, Ding Liu, Song Zhou, Jie Zhang, Jun Liao, Zefeng Guo, Yuzhu Li, Siqiang Yang, Shichao Li, Hua Chen, Ying Guo, Min Li, Lipei Fan, Liuyang Li, Peng Luo, Ming Zhao, Yongguang Liu
Posttransplant complications: molecular mechanisms and therapeutic interventions. MedComm 5 (9) (2024)
Lunbo Tan, Na Wang, Annet M H Galema-Boers, Leonie van Vark-van der Zee, Jeanine Roeters van Lennep, Monique T Mulder, Xifeng Lu, A H Jan Danser, Koen Verdonk
Statins, but not proprotein convertase subtilisin-kexin type 9 inhibitors, lower chemerin in hypercholesterolemia via low-density lipoprotein receptor upregulation. MedComm 5 (9) (2024)
Weicheng Qiu, Jinguo Meng, Zhipeng Su, Wei Xie, Gaojie Song
Structural insight into interleukin-4Rα and interleukin-5 inhibition by nanobodies from a bispecific antibody. MedComm 5 (9) (2024)
Liang Cheng, Chenwei Yang, Junlin Lu, Ming Huang, Ruihui Xie, Sarah Lynch, Justin Elfman, Yuhang Huang, Sen Liu, Siting Chen, Baoqing He, Tianxin Lin, Hui Li, Xu Chen, Jian Huang
Oncogenic SLC2A11-MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability. MedComm 5 (9) (2024)
Yuqing Zhao, Chen Wang, Wei Deng, Lanyang Li, Jiping Liu, Yanghua Shi, Xiang Tao, Jian Zhang, Qi Cao, Chunhui Cai, Xinxin Han
Patient-derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin. MedComm 5 (9) (2024)
Modan Yang, Zuyuan Lin, Li Zhuang, Linhui Pan, Rui Wang, Hao Chen, Zhihang Hu, Wei Shen, Jianyong Zhuo, Xinyu Yang, Huigang Li, Chiyu He, Zhe Yang, Qinfen Xie, Siyi Dong, Junli Chen, Renyi Su, Xuyong Wei, Junjie Yin, Shusen Zheng, Di Lu, Xiao Xu
An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. MedComm 5 (9) (2024)
Qianyi Ming, Jiejie Liu, Zijian Lv, Tiance Wang, Runjia Fan, Yan Zhang, Meixia Chen, Yingli Sun, Weidong Han, Qian Mei
Manganese boosts natural killer cell function via cGAS-STING mediated UTX expression. MedComm 5 (9) (2024)
Rubing Xue, Sijia Liu, Fangfang Zhou
Enhancing the effectiveness of anti-respiratory virus vaccines by bolstering mucosal immunity and cellular defenses. MedComm 5 (9) (2024)
Yingjie Wang, Hongyu Liu, Mengsha Zhang, Jing Xu, Liuxian Zheng, Pengpeng Liu, Jingyao Chen, Hongyu Liu, Chong Chen
Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives. MedComm 5 (9) (2024)
Xuejin Ou, Ge Gao, Inbar A Habaz, Yongsheng Wang
Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies. MedComm 5 (9) (2024)
Wenle He, Wenhui Huang, Lu Zhang, Xuewei Wu, Shuixing Zhang, Bin Zhang
Radiogenomics: bridging the gap between imaging and genomics for precision oncology. MedComm 5 (9) (2024)
Liang Ma, Jie Yu, Yidian Fu, Xiaoyu He, Shengfang Ge, Renbing Jia, Ai Zhuang, Zhi Yang, Xianqun Fan
The dual role of cellular senescence in human tumor progression and therapy. MedComm 5 (9) (2024)
Xiao-Hui Zheng, Xi-Zhao Li, Cao-Li Tang, Yu-Meng Zhang, Ting Zhou, Xiao-Jing Yang, Ying Liao, Yong-Qiao He, Tong-Min Wang, Wen-Qiong Xue, Wei-Hua Jia
Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash. MedComm 5 (9) (2024)
Qingjia Sun, Rui Gao, Yingxin Lin, Xianchao Zhou, Tao Wang, Jian He
Leveraging single-cell RNA-seq for uncovering naïve B cells associated with better prognosis of hepatocellular carcinoma. MedComm 5 (9) (2024)
Yi Qu, Nannan Gao, Shengwei Zhang, Limin Gao, Bing He, Chao Wang, Chunli Gong, Qiuyue Shi, Zhibin Li, Shiming Yang, Yufeng Xiao
Role of N6-methyladenosine RNA modification in cancer. MedComm 5 (9) (2024)
Xiaoyan Lu, Lingqi Yu, Jie Zheng, Anyao Li, Junying Li, He Lou, Wentao Zhang, Hui Guo, Yuzhen Wang, Xuemei Li, Yue Gao, Xiaohui Fan, Jürgen Borlak
miR-106b-5p protects against drug-induced liver injury by targeting vimentin to stimulate liver regeneration. MedComm 5 (9) (2024)
Fanfei Liu, Ruiting Li, Zilin Zhu, Yang Yang, Fang Lu
Current developments of gene therapy in human diseases. MedComm 5 (9) (2024)
Yu-Qing Jin, Hang Yuan, Ya-Fang Liu, Yi-Wen Zhu, Yan Wang, Xiao-Yi Liang, Wei Gao, Zhi-Guang Ren, Xin-Ying Ji, Dong-Dong Wu
Role of hydrogen sulfide in health and disease. MedComm 5 (9) (2024)
Dandan Peng, Cai He, Zimin Chen, Hong Lei, Xiya Huang, Chunjun Ye, Binhan Wang, Ying Hao, Xinyi Du, Shuaiyao Lu, Hongbo Hu, Wei Cheng, Haohao Dong, Jian Lei, Xi-Kun Zhou, Xiangrong Song, Guangwen Lu, Yanping Qian
XBB.1.16-RBD-based trimeric protein vaccine can effectively inhibit XBB.1.16-included XBB subvariant infection. MedComm 5 (9) (2024)